We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
AAOI | Applied Optoelectronics Inc | 11.13 | 0.00 | 0.00% | 6,680 |
AAON | AAON Inc | 86.73 | 0.00 | 0.00% | 60 |
AAPB | GraniteShares ETF Trust GraniteShares | 16.25 | 0.00 | 0.00% | 873 |
AAPD | Direxion Daily AAPL ETF | 23.46 | 0.00 | 0.00% | 4,749 |
AAME | Atlantic American Corporation | 1.96 | 0.00 | 0.00% | 1 |
AAL | American Airlines Group Inc | 14.53 | 0.00 | 0.00% | 1,096,323 |
AACI | Armada Acquisition Corporation I | 11.14 | 0.00 | 0.00% | 54,579 |
AADI | Aadi Bioscience Inc | 1.90 | 0.00 | 0.00% | 113 |
AADR | AdvisorShares Dorsey Wright ADR ETF | 60.77 | 0.00 | 0.00% | 0 |
AAGR | African Agriculture Holdings Inc | 0.32 | 0.00 | 0.00% | 5,842 |
AACG | ATA Creativity Global | 0.89 | 0.00 | 0.00% | 4,154 |
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that an abstract featuring new preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR (chimeric antigen receptor) T cell therapy candidate targeting CD70 positive cancers, has been selected for an oral presentation at the ASGCT 27th Annual Meeting taking place from May 7-11, 2024, in Baltimore, MD. The oral presentation will take place on May 10, 2024 in the Targeted Gene and Cell Therapy session, co-chaired by Adicet Bio’s Chief Scientific Officer, ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that Health Canada has accepted its New Drug Submission (NDS) for trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental disorder. Health Canada has granted Priority Review for Acadia’s submission.
Pilot plant produces qualification samples for strategic customers and demonstrates commercial maturity of internally-developed production process RENO, Nev., April 22, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, announced the completion of construction and start of commissioning of its lithium hydroxide (LiOH) pilot plant marking a significant milestone in the commercialization of its internally-developed processes to access an unrealized domestic primary lithium resource.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,368.56 | -489.39 | -0.73% | 1.3T | 3,451,712,242 |
ETH | Ethereum | 3,187.28 | -14.78 | -0.46% | 382.12B | 1,572,269,834 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 391,101,772 |
BNB | Binance Coin | 606.75 | 1.65 | 0.27% | 95.54B | 411,164,854 |
SOL | Solana | 154.89 | -2.12 | -1.35% | 67.89B | 1,046,903,934 |
STETH | stETH | 3,187.33 | -13.13 | -0.41% | 31.02B | 3,223,223 |
XRP | Ripple | 0.5453 | -0.0113 | -2.03% | 29.67B | 458,317,892 |
USDC | USD Coin | 0.9998 | -0.0002 | -0.02% | 28.07B | 1,117,392,694 |
DOGE | Dogecoin | 0.15956 | -0.00167 | -1.04% | 22.69B | 354,675,621 |
TONCOIN | Wrapped TON Coin | 5.65 | -0.262792 | -4.45% | 19.64B | 150,344,972 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions